Clinical Trial Update: Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) pilot trial of GLY-LOW supplementation in postmenopausal women with obesity has completed, according to the clinical trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Cognitive Impairment
• Hyperlipidemia
• Hypertension
• Insulin Resistance
• Major Depressive Disorder
• Obesity

Drugs mentioned

• GLY-LOW

Snippet

Sponsor: Hoskinson Health and Wellness Clinic | Conditions: Insulin Resistance, Obesity | EARLY_Phase 1 | Status: COMPLETED